Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
allergan
balderton capital
biotech
boston
boston blog main
boston top stories
clinical trials
crispr
cynthia collins
drugs
editas medicine
europe
fundings & exits
gene editing
katrine bosley
leber congenital amaurosis
life sciences
mytomorrows
national blog main
sofinnova partners
startups
tc
What
clinical
2
×
million
2
×
regulatory
2
×
access
allergan
amid
approval
blessing
bosley
ceo
check
crispr
cusp
debate
depart
development
disrupt
drugs
dutch
editas
editing
experimental
funding
gene
humans
katrine
lengthy
medical
medicine
mytomorrows
needs
new
partner
patients
process
raised
raises
read
right
stage
Language
Current search:
regulatory
×
million
×
clinical
×
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@techcrunch.com
9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs